'Noliprel Chiefs'

"Noliprel Chiefs" - a agwọ ọrịa maka ọgwụgwọ nke ọbara mgbali (ma ọ bụ ọbara mgbali dị ka ziri ezi na-akpọ ọrịa a). Tupu ị na-agwa na ihe-nkọwa banyere ọgwụ, ka anyị na nkenke na-akọwa ọrịa. Ọbara mgbali adahade bụghị na mberede, ozugbo; Ọtụtụ ihe na-eme ka ndụ anyị a: nchegbu, ogbenye nri, ịnọkarị otu ... na ọtụtụ ndị ọzọ. Ọ na-eme na mbụ ngosipụta nke ọbara mgbali elu, anyị na-dị adịghị achọpụta; ọ bụ ezie na na mkpa ka elu àgwà ọjọọ na normalize ọbara mgbali. Ọtụtụ mgbe nke a bụ n'ihi na mbụ umengwụ na ndị na-aga na nke dọkịta mgbe iji belata nsogbu na-enweghị ọgwụ na-adịghị nwetara. Ke ahu e nwere irreversible mgbanwe arịa, na-arịa ọrịa nwoke sneaks a nkụchi obi ma ọ bụ ọrịa strok - Ugboro na egwu ọrịa nke oge anyị. Olee otú m pụrụ ka nke a mee?

Mgbe a onye bụ ike, ihe niile na Filiks nke ahụ ya guzozie eguzozie ozu na-arụ ọrụ n'ụzọ doro anya na kpomkwem; ndị mmadụ dị adịghị achọpụta ya. Mbadamba - "podstegivatel" ndị a Filiks; dọkịta na-edepụta ọgwụ ga-akwado ndị na ahaghị nhata. Ya mere, gị ọgwụ ọgwụ dị ka nri, na-enweghị i nwere ike ghara ịdị ndụ.

Ọbara mgbali Mbelata pụtara na otutu. Ha na-eme dị iche iche. A ọma dọkịta, ebe ọ maara na ya ọrịa, o kwesịrị bulie ọgwụ, na-ewere n'ime akaụntụ afọ, comorbidities, na price nke na dị nnọọ mkpa n'ihi na ụfọdụ na edemede nke ndị bi.

"Noliprel Chiefs" - a ọgbọ ọhụrụ nke ọgwụ. Na ngwa ka ọ dị mkpa maara na ọ bụ a jikọrọ nkwadebe, na-agụnye abụọ n'ọrụ Efrata nke, onye ọ bụla na ya onwe ha ụzọ, wee bụrụ na agha ndị ọzọ ọgwụ ọjọọ. "Noliprel Chiefs" nwere perindopril (ATP inhibitor), na indapamide (mamịrị). Mere nye iwu a mamịrị? N'ihi ruru ya edinam mbelata ego nke ọbara-ekesa

Indapamide, eme na akụrụ na ọbara arịa, na-emetụta mmamịrị mmepụta, na-ebelata ọbara mgbali. The ọzọ nọ n'ọrụ akụrụngwa esịne ke "Noliprel" bụ perindopril na-akpata na-abawanye na ọbara mgbali. Ọzọ mmetụta nke perindopril: ọ dịghị tisaa bradykinin endogenous umi na-akpata dilation na arịa. N'ihi ya, abụọ ifịk ifịk mmiri - perindopril na indapamide, nke bụ akụkụ nke "Noliprel" rụọ ọrụ were were, ibe complementing ọ bụla ọzọ.

"Noliprel" na-eji na ọgwụgwọ nke dị iche iche nke ọbara mgbali na congestive obi ọdịda. Ọtụtụ nnyocha na ọrịa gosiri na ọgwụ enwekwu ọbara na myocardium, ebelata elu vaskụla eguzogide, enwekwu IOC, na-abawanye na gbasara obi index; budata mma arụmọrụ ule. The dọkịta na-emekarị na-ahọpụta onye mbadamba a ụbọchị, ọkacha mma tupu nri ụtụtụ. The kacha antihypertensive mmetụta hụrụ mgbe 5 awa na-ekwupụtakwa 24 awa. Normalisation nke ọbara mgbali emee n'ime otu ọnwa na-adịgide ruo ogologo oge.

Ndọrọ ego nke ọgwụ anaghị eme eme. "Noliprel" Mbadamba tinye ahịa ọgwụ n'okpuru akara ụghalaahịa "Noliprel arginine" na "Noliprel Chiefs", nke dị iche naanị na onunu ogwu nke ifịk ifịk mmiri nime ya. Dị "Noliprel" Laboratory "Servier Industrie", France, na "Serdiks Ltd.", Russia. Ahịa ike ịdị iche iche n'etiti 450-700 rubles, nke dị ka ọha na eze.

"Noliprel" n'ozuzu ọma anabata, ma dị ka ọ bụla na nkà mmụta ọgwụ, o nwekwara contraindications. Ọ nwere ike ọ bụghị etinyere ụmụ nwaanyị dị ime na 2-3 trimesters, na ụmụaka na-eto eto. The ọgwụ na-contraindicated na ọrịa na oké impairment nke imeju na-na akụrụ ọrụ. Analọg "Noliprel" nwere ike na ihe ọ bụla na-ere ọgwụ, ma nyochaa na a dọkịta ọgwụ na ntuziaka na-agụ - maka ihe ịga nke ọma ọgwụgwọ. Mgbe ahụ ị ga-ihe ịrụ ụka adịghị pụtara.